DexCom, Inc. (NasdaqGS:DXCM) said it isn't active merger talks, sending the stock up more than 8% after news reports last week that the company was in talks to buy Insulet Corporation (NasdaqGS:PODD). "We do not intend to comment further on this topic and we assume no obligation to make any further announcement or disclosure should circumstances change," Dexcom said.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
164.2 USD | -1.84% | -0.34% | -24.34% |
Mar. 20 | US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady | MT |
Mar. 20 | Insulet Names Ana Maria Chadwick Finance Chief | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.34% | 11.71B | |
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.44% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+11.92% | 25.66B |
- Stock Market
- Equities
- PODD Stock
- News Insulet Corporation
- Dexcom Says Not in Active Merger Talks